Abstract
The efficiency of a stationary magnetic field ( | ∇ B | = 200 mT / cm ) in increasing the bioavailability of a doxorubicin-magnetite nanoparticle conjugate (diameter of 24±19 nm) in the mouse lung was determined by pharmacokinetic investigation using electron spin resonance (ESR). The magnetic field was also found to inhibit the elimination of nanoparticles from the blood and increase the conjugate half-life and bioavailability in the blood.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
